Galecto Biotech
A Swedish company founded in 2011 by leading galectin scientists and biotech executives from Sweden, United Kingdom, and Denmark.
Total raised
€79M
€79,000,000
Funding rounds
1
Investors
9
distinct backers
Active since
2018-09
latest 2018-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood19
base rate 51% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-10-01 | Series C | €79M | Bristol Myers-Squibb,HBM Healthcare Investments,M Ventures,Maverick Ventures,Novo Seeds,OrbiMed+3 more | View deal → |
Investors
9Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce